Moreover, in the presence of the proteasome inhibitor MG132, we conducted a comparison of the ubiquitination level of NAT10 in ESCC cells treated with or without G‐749 using immunoprecipitation. Here, NAT10 is linked to esophageal squamous cell carcinoma.